Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20
Published March 15, 2017 · Recall initiated: January 27, 2017
Summary
FDA records drug Class II recall D-0493-2017, published March 15, 2017 and initiated January 27, 2017. Recalling firm: Mylan Institutional, Inc. (d.b.a. UDL Laboratories); Status: Terminated; Reported quantity: 58 UD100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each); Lot: Batch #3083289; Exp. Date 12/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled
What to do
Voluntary: Firm initiated · Letter
Get an email if MIRTAZAPINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MIRTAZAPINE
- Manufacturer
- Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
- Distributor
- Nationwide
- Lot
- Batch #3083289; Exp. Date 12/2018
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMirtazapine Tablets, USP 15mg, 30-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton,April 22, 2020
- FDAMirtazapine Tablets, USP, 15 mg, 500-count tablets, Rx only, Distributed by: Aurobindo Pharma USA, Inc.December 18, 2019
- FDAMirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, MylanMarch 15, 2017
- FDACalcipotriene Cream 0.0005%, packaged in a) 60g tube, (NDC 66993-877-61), b) 120g tube (NDC 66993-877-78), RxMarch 15, 2017
- FDARisedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19),March 15, 2017
- FDATriForce Peripheral Crossing Set, Individual product is packaged in a Tyvek-film sterilizable outer pouch. TheMarch 8, 2017
Questions about this recall
Was Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20 recalled?
Yes. FDA published recall D-0493-2017 on March 15, 2017. Reported hazard: Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MIRTAZAPINE.